Bioavailability of BI 10773 and Pioglitazone in Healthy Male Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the study was to investigate whether there is a drug-drug interaction
between BI 10773 and pioglitazone when co-administered as multiple oral doses. Therefore, the
relative bioavailabilities of BI 10773 and pioglitazone were determined when both drugs were
given in combination compared with BI 10773 and pioglitazone given alone.